Pharmacotherapy for diabetic retinopathy

Keyphrases

• Diabetic Macular Edema 100%
• Diabetic Retinopathy 100%
• Pharmacotherapy 100%
• Randomized Clinical Trial 66%
• Proliferative Diabetic Retinopathy 66%
• Triamcinolone Acetonide 33%
• Short-term Efficacy 33%
• Combination Therapy 16%
• Clinical Practice 16%
• Monotherapy 16%
• Grid Laser 16%
• Diabetic Retinopathy Clinical Research Network 16%
• Laser Technique 16%
• Antilaser 16%
• Visual Loss 16%
• Pharmacological Therapy 16%
• Anti-vascular Endothelial Growth Factor (anti-VEGF) 16%
• Patients with Diabetes Mellitus 16%
• Improved Control 16%
• Blood Sugar 16%
• Prospective Randomized Clinical Trial 16%
• Laser Therapy 16%
• Blood Pressure Control 16%
• Evidence-based Data 16%

Medicine and Dentistry

• Drug Therapy 100%
• Diabetic Macular Edema 100%
• Diabetic Retinopathy 100%
• Randomized Clinical Trial 83%
• Proliferative Diabetic Retinopathy 66%
• Vasculotropin 33%
• Triamcinolone Acetonide 33%
• Combination Therapy 16%
• Diabetes Mellitus 16%
• Visual Impairment 16%
• Blood Pressure 16%
• Clinical Research 16%
• Monotherapy 16%
• Patient with Diabetes 16%
• Low Level Laser Therapy 16%
• Laser Technique 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetic Macular Edema 100%
• Diabetic Retinopathy 100%
• Pharmacotherapy 100%
• Randomized Clinical Trial 83%
• Proliferative Diabetic Retinopathy 66%
• Vasculotropin 33%
• Triamcinolone Acetonide 33%
• Diabetes Mellitus 16%
• Clinical Research 16%
• Combination Therapy 16%
• Visual Impairment 16%
• Monotherapy 16%